Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y. Sato T, et al. Among authors: inoue e. N Engl J Med. 2018 Feb 8;378(6):529-538. doi: 10.1056/NEJMoa1704827. N Engl J Med. 2018. PMID: 29414279 Free article. Clinical Trial.
CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.
Sato T, Coler-Reilly A, Utsunomiya A, Araya N, Yagishita N, Ando H, Yamauchi J, Inoue E, Ueno T, Hasegawa Y, Nishioka K, Nakajima T, Jacobson S, Izumo S, Yamano Y. Sato T, et al. Among authors: inoue e. PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2479. doi: 10.1371/journal.pntd.0002479. eCollection 2013. PLoS Negl Trop Dis. 2013. PMID: 24130912 Free PMC article.
Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study.
Martin F, Inoue E, Cortese IC, de Almeida Kruschewsky R, Adonis A, Grassi MF, Galvão-Castro B, Jacobson S, Yamano Y, Taylor GP, Bland M. Martin F, et al. Among authors: inoue e. Pilot Feasibility Stud. 2015 Oct 23;1:35. doi: 10.1186/s40814-015-0031-1. eCollection 2015. Pilot Feasibility Stud. 2015. PMID: 27965813 Free PMC article.
Effectiveness of Daily Prednisolone to Slow Progression of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Multicenter Retrospective Cohort Study.
Coler-Reilly ALG, Sato T, Matsuzaki T, Nakagawa M, Niino M, Nagai M, Nakamura T, Takenouchi N, Araya N, Yagishita N, Inoue E, Yamano Y. Coler-Reilly ALG, et al. Among authors: inoue e. Neurotherapeutics. 2017 Oct;14(4):1084-1094. doi: 10.1007/s13311-017-0533-z. Neurotherapeutics. 2017. PMID: 28536850 Free PMC article.
Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis.
Yamakawa N, Yagishita N, Matsuo T, Yamauchi J, Ueno T, Inoue E, Takata A, Nagasaka M, Araya N, Hasegawa D, Coler-Reilly A, Tsutsumi S, Sato T, Araujo A, Casseb J, Gotuzzo E, Jacobson S, Martin F, Puccioni-Sohler M, Taylor GP, Yamano Y; Japan Clinical Research Group on HAM/TSP. Yamakawa N, et al. Among authors: inoue e. Orphanet J Rare Dis. 2020 Jul 3;15(1):175. doi: 10.1186/s13023-020-01451-3. Orphanet J Rare Dis. 2020. PMID: 32620176 Free PMC article.
Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G.
Arai H, Inoue E, Yamaguchi K, Boku N, Hara H, Nishina T, Tsuda M, Shitara K, Shinozaki K, Nakamura S, Hyodo I, Muro K, Sasako M, Terashima M, Nakajima TE. Arai H, et al. Among authors: inoue e. Cancer Med. 2021 Nov;10(21):7673-7682. doi: 10.1002/cam4.4303. Epub 2021 Oct 16. Cancer Med. 2021. PMID: 34655175 Free PMC article. Clinical Trial.
511 results